Pediatrics Doctors in Orangeburg, SC Accepting Medicare

10 Pediatrics doctors found. Showing 1 - 10

Dr. Ben C Pendarvis Jr., M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 940 Holly St Ne, Orangeburg, SC 29115 Phone: 803-536-2725    Fax: 803-534-1441

Tanya Am Nanongkhai, Pediatrics Medicare: Medicare Enrolled Practice Location: 3310 Magnolia St, Orangeburg, SC 29115 Phone: 803-531-6900    Fax: 803-531-6907

Dr. Sandra Stephens, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3310 Magnolia St, Orangeburg, SC 29115 Phone: 803-531-6900    Fax: 803-531-6907

Brigitte Jahoor, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3310 Magnolia St, Orangeburg, SC 29115 Phone: 803-531-6900    Fax: 803-531-6907

Dr. Thomas B. Gue, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 940 Holly St Ne, Orangeburg, SC 29115 Phone: 803-536-2725    Fax: 803-534-1441

Dr. Virginia Wagner, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3310 Magnolia St, Orangeburg, SC 29115 Phone: 803-531-6900    Fax: 803-531-6907

Nakia Smoak Smith, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1995 Saint Matthews Rd, Orangeburg, SC 29118 Phone: 803-928-5525    Fax: 803-928-5505

Dr. Karen L. Connelly, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1995 Saint Matthews Rd, Orangeburg, SC 29118 Phone: 803-928-5525    Fax: 803-928-5505

Dr. Tracy D. Macpherson, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 940 Holly St Ne, Orangeburg, SC 29115 Phone: 803-536-2725    Fax: 803-534-1441

Charles J Kilgore, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 940 Holly St, Orangeburg, SC 29115 Phone: 803-536-2725    Fax: 803-534-3118

News Archive

DARA BioSciences receives NASDAQ non-compliance notice

On March 16, 2010, DARA BioSciences, Inc. received notice from the Listing Qualifications Staff of The NASDAQ Stock Market LLC indicating that the Company had not timely regained compliance with the $1.00 bid price requirement, as set forth in Listing Rule 5550(a)(2). DARA plans to timely request a hearing before a NASDAQ Listing Qualifications Panel, at which it will request the continued listing of its securities on The NASDAQ Capital Market pending the completion of its plan to evidence compliance with the minimum bid price requirement.

Performing x-rays using iodine dye increases risk for kidney failure

Performing x-rays using iodine dye places patients with impaired kidney function at increased risk for kidney failure. Known as Contrast-Induced Nephropathy (ne-FROPP-a- thee) or ''CIN,'' this complication is the third most common cause of hospital-acquired kidney failure in the United States and Europe, accounting for 10-12 percent of all such cases.

Allen Institute, Blue Brain Project collaborate to develop simulation-based tools to study neurons

The Allen Institute for Brain Science and the Blue Brain Project are deepening their collaboration. Today, the US-based Allen Institute is releasing a set of 40 computer models of neurons from the mouse visual cortex, created using tools developed by the Swiss-based Blue Brain Project at EPFL. Using Blue Brain technology, the researchers were able to reproduce the physiology and electrical activity of the neurons with an extremely high level of detail.

Blocking stress protein decreases Alzheimer's peptide

Scientists revealed in November 2006 that stress increases production in mice of a brain peptide critical to Alzheimer's disease.

Scientists find that DNA repair drug could help treat leukaemia, other cancers

A team of scientists led by Research Associate Professor Motomi Osato and Professor Yoshiaki Ito from the Cancer Science Institute of Singapore at the National University of Singapore found that a drug originally designed for killing a limited type of cancer cells with DNA repair defects could potentially be used to treat leukaemia and other cancers.

Read more Medical News

› Verified 4 days ago